Clinuvel, Inc.
Quick facts
Phase 3 pipeline
- Afamelanotide and NB-UVB Light · Dermatology
Afamelanotide stimulates melanin production via alpha-melanocyte-stimulating hormone (α-MSH) receptor activation, which is then enhanced by controlled NB-UVB light exposure to increase skin pigmentation and photoprotection.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: